-
Legacy heavyweight Enstar and a consortium comprising Randall & Quilter (R&Q) and Axa are facing off in the final round of the bidding process for the Novae legacy book, The Insurance Insider can reveal.
-
AIG is said to be shopping a legacy book of life settlements valued at as much as $2bn, with private equity firms taking a serious look, as the giant multi-line insurer winds down a strategy of asset sales begun by former CEO Peter Hancock
-
London carriers posted an 8.4 percent expansion in gross written premium (GWP) in the first half of the year as the group's combined top line reached $4.6bn, using five-year average exchange rates.
-
The regulatory requirements surrounding Part VII portfolio transfers look set to increase under proposals from the Financial Conduct Authority (FCA).
-
Zurich has reached the second stage in the disposal of its EUR400mn ($470mn) German legacy medical malpractice book, having selected three run-off carriers to participate in the next round of bids, The Insurance Insider understands.
-
The legacy market has long eyed the array of continental European liabilities piled up on carrier balance sheets, just waiting to be released.
-
Hamburg-headquartered insurer Schwarzmeer und Ostsee Versicherungsaktiengesellschaft, known as Sovag, is bringing a legacy book holding EUR120mn ($140mn) of gross reserves to market, The Insurance Insider understands.
-
The reinsurance community is expecting further demand for adverse development covers (ADCs) as a combination of soft market conditions, low interest rates and reserve adequacy concerns pushes carriers to scrutinise their back books.
-
Darag CFO Simon Minshall has left the company to be replaced by Michael Trotman, former CFO of retailer TM Lewin, The Insurance Insider understands
-
Italian carrier Generali is gearing up sell its EUR44bn ($50bn) German life book, Reuters reported, citing sources close to the matter.
-
No one could accuse AmTrust CEO Barry Zyskind and his team of shying away from a challenge.
-
In inking a multi-hundred million dollar adverse development deal with Premia, AmTrust has sought to provide investors with further clarity over its financial position.